Company registration number 09448243 (England and Wales)
WELLINGTON HEALTHCARE (ARDEN) LTD
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
WELLINGTON HEALTHCARE (ARDEN) LTD
COMPANY INFORMATION
Directors
Mr L Ramos
Mrs A Tan-Ramos
Secretary
Mrs A Tan-Ramos
Company number
09448243
Registered office
34 Scarisbrick New Road
Southport
PR8 6QE
Auditor
MHA
Richard House
9 Winckley Square
Preston
PR1 3HP
WELLINGTON HEALTHCARE (ARDEN) LTD
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Directors' responsibilities statement
5
Independent auditor's report
6 - 8
Statement of comprehensive income
9
Balance sheet
10
Statement of changes in equity
11
Notes to the financial statements
12 - 24
WELLINGTON HEALTHCARE (ARDEN) LTD
STRATEGIC REPORT
FOR THE YEAR ENDED 31 JULY 2025
- 1 -
The directors present the strategic report for the year ended 31 July 2025.
Review of the business
Wellington Healthcare (Arden) Ltd continues to deliver high-quality residential, nursing, and dementia care across its services. During the year, the group maintained a broad operational footprint while undertaking a strategic review to ensure long-term sustainability and quality of delivery.
As part of this review, two externally leased homes were returned to the landlord. These homes had underperformed and placed pressure on the wider group’s financial performance. This decision enabled the group to sharpen its focus, improve financial performance, and focus resources on high-performing locations and ensure quality outcomes for residents across the estate.
Our staff remain the backbone of our operations. We continue to prioritise training, support, and wellbeing initiatives to empower teams delivering care. We are also advancing our digital systems to enhance operational efficiency and enrich the experience of both residents and their families.
We thank our staff, residents, families, and stakeholders for their continued support, which enables us to move forward with strength and clarity.
Future developments
Wellington Healthcare (Arden) Ltd remains dedicated to pursuing responsible and sustainable growth within a dynamic market environment. To achieve this, we are continually investing in our personnel, modernising our digital systems, and refining care pathways across our entire portfolio.
Our future progression is strongly supported by recent improvements in corporate governance. By enhancing internal oversight processes and conducting rigorous internal audits and risk reviews, management is well-equipped to monitor principal uncertainties ensuring operational continuity as our portfolio expands.
Furthermore, we are focused on strengthening our recruitment capabilities through a combination of local hiring strategies and overseas pathways. This effort is driven by a newly implemented talent acquisition system, which streamlines candidate engagement and optimizes the hiring process across the estate.
Principal risks and uncertainties
Key risks managed by the business include:
Credit Risk: Mitigated primarily through established partnerships with local authorities
Liquidity Risk: Closely monitored to ensure the group can meet its financial obligations as they fall due
Interest Rate Risk: The Group’s borrowings are at variable rates; management reviews hedging options as appropriate
Competitor Pressure: Managed through continuous brand development and strict adherence to regulatory compliance
Key Personnel Risk: Addressed via succession planning and market-aligned compensation
Key performance indicators
Turnover: Decreased by approximately 13.76% in 2025 compared to 2024. This decrease was primarily due to the divestment of two units
Gross Profit Margin: Improved substantially from 20.40% in 2024 to 25.66% in 2025
CQC Ratings: The Senior Leadership Team, Board of Directors, and governance and compliance personnel maintain rigorous oversight of facilities rated "Inadequate". Following the decision to replace the on-site management team, service provision has steadily improved post year end. This turnaround is demonstrated by the positive outcome of the most recent local authority inspection, which has also enabled the opening of an additional unit on-site
Labour Margin: The labour margin decreased by 4.44 percentage points, dropping from 72.54% in 2024 down to 68.10% in 2025
WELLINGTON HEALTHCARE (ARDEN) LTD
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 2 -
Environmental, Social, and Governance (ESG) and Community Commitment
We recognise that our responsibilities extend beyond care delivery. Environmentally, we continue to assess opportunities for greater energy efficiency across our estate. Socially, we remain committed to local employment and inclusive hiring. From a governance perspective, we have strengthened oversight processes and maintained rigorous internal audit and risk reviews.
We are also deeply invested in the communities we serve — engaging with local authorities, providing career pathways in care, and supporting families with compassionate end-of-life services. These values will continue to underpin our growth and decision-making in the years ahead.
Mr L Ramos
Director
29 July 2026
WELLINGTON HEALTHCARE (ARDEN) LTD
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 JULY 2025
- 3 -
The directors present their annual report and financial statements for the year ended 31 July 2025.
Principal activities
The principal activity of the company continued to be that of the operation and provision of special dementia care centres.
Results and dividends
The results for the year are set out on page 9.
No ordinary dividends were paid. The directors do not recommend payment of a final dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Mr L Ramos
Mrs A Tan-Ramos
Disabled persons
Applications for employment by disabled persons are always fully considered, bearing in mind the aptitudes of the applicant concerned. In the event of members of staff becoming disabled, every effort is made to ensure that their employment within the company continues and that the appropriate training is arranged. It is the policy of the company that the training, career development and promotion of disabled persons should, as far as possible, be identical to that of other employees.
Employee involvement
The company's policy is to consult and discuss with employees, through staff councils and at meetings, matters likely to affect employees' interests.
Information about matters of concern to employees is given through information bulletins and reports which seek to achieve a common awareness on the part of all employees of the financial and economic factors affecting the company's performance.
There is no employee share scheme at present, but the directors may consider the introduction of such a scheme as a means of further encouraging the involvement of employees in the company's performance.
Auditor
The auditor, MHA, is deemed to be reappointed under section 487(2) of the Companies Act 2006.
Strategic report
The company has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the company's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. It has done so in respect of principal risks and uncertainties and future developments.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.
WELLINGTON HEALTHCARE (ARDEN) LTD
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 4 -
Medium-sized companies exemption
This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.
On behalf of the board
Mr L Ramos
Director
29 July 2026
WELLINGTON HEALTHCARE (ARDEN) LTD
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 JULY 2025
- 5 -
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
WELLINGTON HEALTHCARE (ARDEN) LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF WELLINGTON HEALTHCARE (ARDEN) LTD
- 6 -
Opinion
We have audited the financial statements of Wellington Healthcare (Arden) Ltd (the 'company') for the year ended 31 July 2025 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 31 July 2025 and of its profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
WELLINGTON HEALTHCARE (ARDEN) LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF WELLINGTON HEALTHCARE (ARDEN) LTD (CONTINUED)
- 7 -
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
Matters on which we are required to report by exception
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud, is detailed below:
Enquiries with management about any known or suspected instances of non-compliance with laws and regulations;
Enquires with management about any known or suspected instances of fraud;
Auditing the risk of fraud in revenue by testing a sample of transactions throughout the year for occurrence and reviewing post year end credit notes raised;
Examination of journal entries and other adjustments to test for appropriateness and identify any instances of management override of controls;
Review of legal and professional expenditure to identify any evidence of ongoing litigation or enquiries.
WELLINGTON HEALTHCARE (ARDEN) LTD
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF WELLINGTON HEALTHCARE (ARDEN) LTD (CONTINUED)
- 8 -
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Paul Williams BA(Hons) FCA
Senior Statutory Auditor
For and on behalf of MHA, Statutory Auditor
Preston, United Kingdom
MHA is the trading name of MHA Audit Services LLP, a limited liability partnership in England and Wales (registered number OC455542)
WELLINGTON HEALTHCARE (ARDEN) LTD
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 JULY 2025
- 9 -
2025
2024
Notes
£
£
Turnover
3
19,299,460
22,379,431
Cost of sales
(14,346,373)
(17,813,065)
Gross profit
4,953,087
4,566,366
Administrative expenses
(3,588,250)
(5,130,020)
Other operating income
63,456
471,770
Operating profit/(loss)
4
1,428,293
(91,884)
Interest payable and similar expenses
6
(1,975)
(43,199)
Profit/(loss) before taxation
1,426,318
(135,083)
Tax on profit/(loss)
7
(321,738)
(16,049)
Profit/(loss) for the financial year
1,104,580
(151,132)
The profit and loss account has been prepared on the basis that all operations are continuing operations.
WELLINGTON HEALTHCARE (ARDEN) LTD
BALANCE SHEET
- 10 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
9
763,843
729,425
Current assets
Debtors
10
3,521,511
3,519,870
Cash at bank and in hand
702,683
838,913
4,224,194
4,358,783
Creditors: amounts falling due within one year
11
(3,486,021)
(4,592,971)
Net current assets/(liabilities)
738,173
(234,188)
Total assets less current liabilities
1,502,016
495,237
Creditors: amounts falling due after more than one year
12
(374,650)
(447,650)
Provisions for liabilities
Deferred tax liability
13
54,608
79,409
(54,608)
(79,409)
Net assets/(liabilities)
1,072,758
(31,822)
Capital and reserves
Called up share capital
15
100
100
Profit and loss reserves
1,072,658
(31,922)
Total equity
1,072,758
(31,822)
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 29 July 2026 and are signed on its behalf by:
Mr L Ramos
Director
Company registration number 09448243 (England and Wales)
WELLINGTON HEALTHCARE (ARDEN) LTD
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 JULY 2025
- 11 -
Share capital
Profit and loss reserves
Total
£
£
£
Balance at 1 August 2023
100
119,210
119,310
Year ended 31 July 2024:
Loss and total comprehensive income
-
(151,132)
(151,132)
Balance at 31 July 2024
100
(31,922)
(31,822)
Year ended 31 July 2025:
Profit and total comprehensive income
-
1,104,580
1,104,580
Balance at 31 July 2025
100
1,072,658
1,072,758
WELLINGTON HEALTHCARE (ARDEN) LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2025
- 12 -
1
Accounting policies
Company information
Wellington Healthcare (Arden) Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 34 Scarisbrick New Road, Southport, PR8 6QE.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements:
Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;
Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues: Interest income/expense and net gains/losses for financial instruments not measured at fair value; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;
Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.
The financial statements of the company are consolidated in the financial statements of Bloomcare Group Limited. These consolidated financial statements are available from its registered office, 34 Scarisbrick New Road, Southport, PR8 6QE.
WELLINGTON HEALTHCARE (ARDEN) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 13 -
1.2
Going concern
The company participates in a group lending facility, and its going concern assessment is considered in conjunction with the wider group. Post year-end, the ultimate parent company, Bloomcare Group Limited, successfully completed a refinancing agreement with Cynergy to replace the previous facility. The directors have reviewed the group's detailed forecasts extending to July 2031 alongside the applicable covenants under the new Cynergy facility. Based on the robust group position and the security of the new refinancing terms, the directors continue to adopt the going concern basis of accounting in preparing the financial statements.true
Occupancy levels remain stable with promising growth projected for future periods. Furthermore, despite operational challenges, including escalating payroll costs, increased minimum wage requirements, national insurance, and rising overheads, the group has successfully sustained and improved its profitability following a comprehensive strategic review of its operational estate.
The continuous enhancement of the Senior Management Team and the deployment of a new strategic plan reinforce the directors' confidence in maintaining elevated performance standards.
Consequently, based on current trading, detailed projections, and the newly established facility, at the time of approving the financial statements, the directors have a reasonable expectation that both the company and wider group possesses adequate resources to continue in operational existence for the foreseeable future. Thus, the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.3
Turnover
Turnover represents the invoiced sales of care home accommodation and nursing services excluding VAT.
Revenue from contracts for the provision of care home and nursing services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably, The stage of completion is calculated by reference to the period of stay within the carehome and only when nursing services are recognised and subsequently invoiced. Where the outcome cannot be estimated reliably, revenue is recognised only to the extent of the expenses recognised that are recoverable.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:
Land and buildings leasehold
Straight line at 20%
Plant and machinery
Straight line at 20%
Fixtures, fittings & equipment
Straight line at 20%
Office Equipment
Straight line at 20%
Motor vehicles
Straight line at 20%
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
WELLINGTON HEALTHCARE (ARDEN) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 14 -
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.6
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.7
Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
All of the company's financial assets are classed as basic financial assets.
WELLINGTON HEALTHCARE (ARDEN) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 15 -
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Other financial liabilities
All of the company's financial liabilities are classed as basic financial liabilities.
Derecognition of financial liabilities
Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.
1.8
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
WELLINGTON HEALTHCARE (ARDEN) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 16 -
1.9
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.10
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.11
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.12
Leases
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.
WELLINGTON HEALTHCARE (ARDEN) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
1
Accounting policies
(Continued)
- 17 -
1.13
Government grants
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.
A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.
1.14
Pension costs and other post-retirement benefits
The company operates defined contribution schemes for the benefit of its employees. Contributions payable are charged to the profit and loss account in the year they are payable.
2
Judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
In management's opinion, there are no critical judgements or key sources of estimation uncertainty that could have a significant impact on the financial statements.
3
Turnover and other revenue
2025
2024
£
£
Turnover analysed by class of business
Operation of care centres
19,299,460
22,379,431
2025
2024
£
£
Other revenue
Grants received
-
36,250
WELLINGTON HEALTHCARE (ARDEN) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 18 -
4
Operating profit/(loss)
2025
2024
Operating profit/(loss) for the year is stated after charging/(crediting):
£
£
Government grants
-
(36,250)
Fees payable to the company's auditor for the audit of the company's financial statements
11,538
15,456
Depreciation of owned tangible fixed assets
290,705
352,882
Impairment of owned tangible fixed assets
193,213
Operating lease charges
469,270
1,151,026
5
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Management and head office
3
6
Care staff
541
701
Total
544
707
Their aggregate remuneration comprised:
2025
2024
£
£
Wages and salaries
11,392,416
13,859,232
Social security costs
944,675
1,118,319
Pension costs
184,483
242,723
12,521,574
15,220,274
6
Interest payable and similar expenses
2025
2024
£
£
Other interest
1,975
43,199
7
Taxation
2025
2024
£
£
Current tax
Group tax relief
101,405
28,753
WELLINGTON HEALTHCARE (ARDEN) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
7
Taxation
2025
2024
£
£
(Continued)
- 19 -
Deferred tax
Origination and reversal of timing differences
261,080
(12,704)
Adjustment in respect of prior periods
(40,747)
Total deferred tax
220,333
(12,704)
Total tax charge
321,738
16,049
The actual charge for the year can be reconciled to the expected charge/(credit) for the year based on the profit or loss and the standard rate of tax as follows:
2025
2024
£
£
Profit/(loss) before taxation
1,426,318
(135,083)
Expected tax charge/(credit) based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
356,580
(33,771)
Tax effect of expenses that are not deductible in determining taxable profit
5,905
12,358
Adjustments in respect of prior years
(40,747)
Depreciation on assets not qualifying for tax allowances
4,188
Fixed assets tax adjustments
(15,029)
Impairment of fixed assets
48,303
Taxation charge for the year
321,738
16,049
8
Impairments
Impairment tests have been carried out where appropriate and the following impairment losses have been recognised in profit or loss:
2025
2024
Notes
£
£
In respect of:
Property, plant and equipment
9
193,213
Recognised in:
Administrative expenses
-
193,213
WELLINGTON HEALTHCARE (ARDEN) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
8
Impairments
(Continued)
- 20 -
On 19 August 2024, the company transferred operation of two care homes over to a new operator. As part of the transfer, fixed assets with a net book value of £193,213 were disposed of by the company for no proceeds and therefore impaired to £nil at the previous year end.
9
Tangible fixed assets
Land and buildings leasehold
Plant and machinery
Fixtures, fittings & equipment
Office Equipment
Motor vehicles
Total
£
£
£
£
£
£
Cost
At 1 August 2024
78,176
139,894
1,502,508
102,985
9,060
1,832,623
Additions
109,713
195,658
11,552
8,200
325,123
Disposals
(78,176)
(2,145)
(293,353)
(30,181)
(403,855)
At 31 July 2025
247,462
1,404,813
84,356
17,260
1,753,891
Depreciation and impairment
At 1 August 2024
78,176
64,058
868,342
84,921
7,701
1,103,198
Depreciation charged in the year
26,587
251,248
11,238
1,632
290,705
Eliminated in respect of disposals
(78,176)
(2,145)
(293,353)
(30,181)
(403,855)
At 31 July 2025
88,500
826,237
65,978
9,333
990,048
Carrying amount
At 31 July 2025
158,962
578,576
18,378
7,927
763,843
At 31 July 2024
75,836
634,166
18,064
1,359
729,425
More information on impairment movements in the previous year is given in note 8.
10
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
866,994
1,496,396
Amounts owed by group undertakings
2,482,363
1,546,042
Other debtors
45,536
8,223
Prepayments and accrued income
126,618
224,075
3,521,511
3,274,736
WELLINGTON HEALTHCARE (ARDEN) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
10
Debtors
(Continued)
- 21 -
2025
2024
Amounts falling due after more than one year:
£
£
Deferred tax asset (note 13)
245,134
Total debtors
3,521,511
3,519,870
11
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
335,228
484,671
Taxation and social security
214,769
522,138
Other creditors
2,266,997
2,745,688
Accruals and deferred income
669,027
840,474
3,486,021
4,592,971
12
Creditors: amounts falling due after more than one year
2025
2024
£
£
Other creditors
374,650
447,650
13
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:
Liabilities
Liabilities
Assets
Assets
2025
2024
2025
2024
Balances:
£
£
£
£
Accelerated capital allowances
58,181
80,844
-
-
Tax losses
-
-
-
245,134
Retirement benefit obligations
(3,573)
(1,435)
-
-
54,608
79,409
-
245,134
WELLINGTON HEALTHCARE (ARDEN) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
13
Deferred taxation
(Continued)
- 22 -
2025
Movements in the year:
£
Asset at 1 August 2024
(165,725)
Charge to profit or loss
220,333
Liability at 31 July 2025
54,608
The company has not finalised its capital expenditure programme for the next financial year and therefore an assessment as to the likely movement of timing differences cannot reasonably be made.
At the year end, the company had estimated tax losses of £nil (2024: £980,535).
14
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
184,483
242,723
The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.
15
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary Shares of £1 each
100
100
100
100
16
Financial commitments, guarantees and contingent liabilities
The company has provided a debenture to a lender in the parent company which at 31 July 2025 amounted to £7,608,316.
WELLINGTON HEALTHCARE (ARDEN) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 23 -
17
Operating lease commitments
Lessee
At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:
2025
2024
£
£
Within one year
824,457
812,882
Between two and five years
3,243,758
3,228,460
In over five years
10,772,000
11,576,000
14,840,215
15,617,342
18
Events after the reporting date
After the year end, the company agreed a reduction in historic rent charged by its landlords (who are related by common shareholders and directors). An amount of £363,630 of rent previously charged up to 31 July 2025 was foregone by the landlord.
Therefore, the company has recognised this reduction in the 31 July 2025 financial statements.
19
Related party transactions
Transactions with related parties
During the year the company entered into the following transactions with related parties:
Category
Description of
Income
Expenditure
transaction
2025
2024
2025
2024
£
£
£
£
Other related parties
Rent
440,370
804,000
Balances with related parties
The following amounts were outstanding at the reporting end date:
Category
Amounts owed by
Amounts owed to
related parties
related parties
2025
2024
2025
2024
£
£
£
£
Fellow group companies
1,749,322
976,888
Other related parties
44,800
6,274
693,293
567,787
Other information
Details of guarantees provided in respect of related parties can be found in note 16.
The company has taken advantage of the exemption permitted under Section 33.1A from disclosing transactions with the parent and fellow subsidiary companies.
WELLINGTON HEALTHCARE (ARDEN) LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JULY 2025
- 24 -
20
Ultimate controlling party
The company is a subsidiary of Bloomcare Group Limited, a company registered in England and Wales. The registered office is 34 Scarisbrick New Road, Southport, United Kingdom, PR8 6QE.
The consolidated financial statements of the group are available to the public and may be obtained from Companies House, Cardiff or from its registered office.
The following are the parents of the largest and smallest groups in which this company's results are consolidated:
Largest group
Bloomcare Group Limited
Smallest group
Bloomcare Group Limited
2025-07-312024-08-01falsefalsefalseCCH SoftwareCCH Accounts Production 2026.100Mr L RamosMrs A Tan-RamosMrs A Tan-Ramos094482432024-08-012025-07-3109448243bus:Director12024-08-012025-07-3109448243bus:CompanySecretaryDirector12024-08-012025-07-3109448243bus:CompanySecretary12024-08-012025-07-3109448243bus:Director22024-08-012025-07-3109448243bus:RegisteredOffice2024-08-012025-07-31094482432025-07-31094482432023-08-012024-07-3109448243core:RetainedEarningsAccumulatedLosses2023-08-012024-07-3109448243core:RetainedEarningsAccumulatedLosses2024-08-012025-07-31094482432024-07-3109448243core:LandBuildings2025-07-3109448243core:PlantMachinery2025-07-3109448243core:FurnitureFittings2025-07-3109448243core:ComputerEquipment2025-07-3109448243core:MotorVehicles2025-07-3109448243core:LandBuildings2024-07-3109448243core:PlantMachinery2024-07-3109448243core:FurnitureFittings2024-07-3109448243core:ComputerEquipment2024-07-3109448243core:MotorVehicles2024-07-3109448243core:CurrentFinancialInstrumentscore:WithinOneYear2025-07-3109448243core:CurrentFinancialInstrumentscore:WithinOneYear2024-07-3109448243core:Non-currentFinancialInstrumentscore:AfterOneYear2025-07-3109448243core:Non-currentFinancialInstrumentscore:AfterOneYear2024-07-3109448243core:ShareCapital2025-07-3109448243core:ShareCapital2024-07-3109448243core:RetainedEarningsAccumulatedLosses2025-07-3109448243core:RetainedEarningsAccumulatedLosses2024-07-3109448243core:ShareCapital2023-07-3109448243core:RetainedEarningsAccumulatedLosses2023-07-3109448243core:ShareCapitalOrdinaryShareClass12025-07-3109448243core:ShareCapitalOrdinaryShareClass12024-07-3109448243core:LandBuildingscore:LongLeaseholdAssets2024-08-012025-07-3109448243core:PlantMachinery2024-08-012025-07-3109448243core:FurnitureFittings2024-08-012025-07-3109448243core:ComputerEquipment2024-08-012025-07-3109448243core:MotorVehicles2024-08-012025-07-310944824312024-08-012025-07-310944824312023-08-012024-07-3109448243core:UKTax2024-08-012025-07-3109448243core:UKTax2023-08-012024-07-310944824322024-08-012025-07-310944824322023-08-012024-07-310944824332024-08-012025-07-310944824332023-08-012024-07-3109448243core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-07-3109448243core:PlantMachinery2024-07-3109448243core:FurnitureFittings2024-07-3109448243core:ComputerEquipment2024-07-3109448243core:MotorVehicles2024-07-31094482432024-07-3109448243core:LandBuildingscore:LeasedAssetsHeldAsLessee2025-07-3109448243core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-08-012025-07-3109448243core:CurrentFinancialInstruments2025-07-3109448243core:CurrentFinancialInstruments2024-07-3109448243core:Non-currentFinancialInstruments2025-07-3109448243core:Non-currentFinancialInstruments2024-07-3109448243core:Non-currentFinancialInstruments12025-07-3109448243core:Non-currentFinancialInstruments12024-07-3109448243bus:OrdinaryShareClass12024-08-012025-07-3109448243bus:OrdinaryShareClass12025-07-3109448243bus:OrdinaryShareClass12024-07-3109448243core:WithinOneYear2025-07-3109448243core:WithinOneYear2024-07-3109448243core:BetweenTwoFiveYears2025-07-3109448243core:BetweenTwoFiveYears2024-07-3109448243core:MoreThanFiveYears2025-07-3109448243core:MoreThanFiveYears2024-07-3109448243core:OtherRelatedPartiescore:RentalExpenseTransactions2024-08-012025-07-3109448243core:AllSubsidiaries2024-08-012025-07-3109448243core:OtherRelatedPartiescore:RentalExpenseTransactions2023-08-012024-07-3109448243core:AllSubsidiaries2025-07-3109448243core:AllSubsidiaries2024-07-3109448243bus:PrivateLimitedCompanyLtd2024-08-012025-07-3109448243bus:FRS1022024-08-012025-07-3109448243bus:Audited2024-08-012025-07-3109448243bus:FullAccounts2024-08-012025-07-31xbrli:purexbrli:sharesiso4217:GBPiso4217:ALL